Research Examining Gilteritinib In Newly Diagnosed AML

Research Examining Gilteritinib In Newly Diagnosed AML

obr

1 year
117 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
John Burke, MD Hematologist/Oncologist and Associate Chair of the US Oncology Hematology Research Program, Rocky Mountain Cancer Centers Discusses Research Examining Gilteritinib In Newly Diagnosed AML At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Up Next Autoplay